Detalhe da pesquisa
1.
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors.
Ann Oncol
; 35(2): 221-228, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072158
2.
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Ann Oncol
; 33(9): 968-980, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716907
3.
Complete response of advanced cutaneous squamous cell and basal cell carcinomas with sequential cemiplimab and sonidegib therapy.
J Eur Acad Dermatol Venereol
; 36 Suppl 1: 66-69, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855253
4.
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences.
Br J Dermatol
; 185(1): 101-109, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33454993
5.
Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS.
J Eur Acad Dermatol Venereol
; 35(8): 1678-1685, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931910
6.
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries.
J Eur Acad Dermatol Venereol
; 35(5): 1119-1132, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326646
7.
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion.
J Eur Acad Dermatol Venereol
; 34(9): 1944-1956, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31990414
8.
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force.
J Eur Acad Dermatol Venereol
; 34(10): 2183-2197, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32840022
9.
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
Br J Dermatol
; 179(2): 309-319, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29432644
10.
Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.
Ann Oncol
; 28(10): 2581-2587, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961848
11.
Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study.
Ann Oncol
; 28(5): 1137-1144, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444112
12.
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.
Ann Oncol
; 28(3): 634-641, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993793
13.
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial.
Ann Oncol
; 28(6): 1380-1387, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327988
14.
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.
Ann Oncol
; 28(7): 1631-1639, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475671
15.
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial.
Ann Oncol
; 27(8): 1625-32, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287206
16.
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).
Ann Oncol
; 27(10): 1947-53, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502712
17.
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.
Ann Oncol
; 26(11): 2267-74, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26410620
18.
Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE study.
J Eur Acad Dermatol Venereol
; 34(9): e526-e529, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277508
19.
Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.
Ann Oncol
; 25(1): 246-50, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24276025
20.
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine.
Ann Oncol
; 25(7): 1428-1436, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24769640